{"data":{"map_credentials":{"key":"AIzaSyCm2fvz-c1ZFKb-T2advJ9eI1igrfhBdH4","secret":"CmIaSbT5VzG6XpgXsr-j9RXeBhY="},"fact_copy":null,"species":[{"species_label":"Dogs","icon":"https:\/\/vetmedin.com\/sites\/default\/files\/2025-07\/Dog-Icon.png","products":[{"pid":"262","sku":"168539,168541","isi":"https:\/\/docs.boehringer-ingelheim.com\/PI\/Theras\/Vetmedin-CA1_Prescribing_Information.pdf","name":"\u003Ch4\u003EVETMEDIN\u003Csup\u003E\u00ae\u003C\/sup\u003E-CA1 (pimobendan)\u0026nbsp;\u003Cbr\u003EChewable Tablets\u003C\/h4\u003E","active_ingredients":"\u003Cdiv class=\u0022home_product_text\u0022\u003E\u003Cp\u003EVETMEDIN\u00ae-CA1 Chewable Tablets treat an early stage of the heart disease MMVD to give dogs up to an average of 15.6 more months of symptom-free life.\u00b9\u003C\/p\u003E\u003Cp\u003EIt\u0027s the only medication (conditionally) approved by the FDA to delay the onset of heart failure.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022buyflow_text\u0022\u003E\u003Cp\u003EFor dogs in an early stage of myxomatous mitral valve disease (MMVD).\u003C\/p\u003E\u003Cp\u003EIt\u0027s the medication (conditionally) approved by the FDA to delay the onset of heart failure.\u003C\/p\u003E\u003C\/div\u003E","pack_shot":"https:\/\/vetmedin.com\/sites\/default\/files\/2025-12\/vetmedin-ca1-1000x770_1.webp","protection_against_list":[]},{"pid":"263","sku":"183801","isi":"https:\/\/docs.boehringer-ingelheim.com\/VetmedinSolutionPI_2024.pdf","name":"\u003Cp class=\u0022h4\u0022\u003EVETMEDIN\u003Csup\u003E\u00ae\u003C\/sup\u003E Solution\u0026nbsp;\u003Cbr\u003E(pimobendan oral solution)\u003C\/p\u003E","active_ingredients":"\u003Cdiv class=\u0022home_product_text\u0022\u003E\u003Cp\u003EAn oral solution that\u0027s flavorless for dogs who prefer a liquid medication.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022buyflow_text\u0022\u003E\u003Cp\u003EAn oral solution that\u0027s flavorless for dogs that prefer a liquid medication.\u003C\/p\u003E\u003Cp\u003EFor dogs that have already progressed to congestive heart failure due to Myxomatous Mitral Valve Disease (MMVD) or Dilated cardiomyopathy (DCM).\u003C\/p\u003E\u003C\/div\u003E","pack_shot":"https:\/\/vetmedin.com\/sites\/default\/files\/2025-12\/vetmedin-solution-1000x770.webp","protection_against_list":[]},{"pid":"264","sku":"103183,103184,103185,103186","isi":"https:\/\/docs.boehringer-ingelheim.com\/PI\/Theras\/Vetmedin_PI.pdf","name":"\u003Cp class=\u0022h4\u0022\u003EVETMEDIN\u003Csup\u003E\u00ae\u003C\/sup\u003E (pimobendan)\u0026nbsp;\u003Cbr\u003EChewable Tablets\u003C\/p\u003E","active_ingredients":"\u003Cdiv class=\u0022home_product_text\u0022\u003E\u003Cp\u003EBeef-flavored and half-scored to meet the dosing needs for dogs who prefer chews.\u003C\/p\u003E\u003C\/div\u003E\u003Cdiv class=\u0022buyflow_text\u0022\u003E\u003Cp\u003EBeef-flavored and half-scored to meet the dosing needs for dogs who prefer chews.\u003C\/p\u003E\u003Cp\u003EFor dogs that have already progressed to congestive heart failure due to Myxomatous Mitral Valve Disease (MMVD) or Dilated cardiomyopathy (DCM).\u003C\/p\u003E\u003C\/div\u003E","pack_shot":"https:\/\/vetmedin.com\/sites\/default\/files\/2025-12\/vetmedin-chewable-1000x770.webp","protection_against_list":[]}]}],"default_lat":"","default_lng":"","state_flag":"multiple_products"}}